Predicting Long-Term Response to Strong Opioids in Low Back Pain Patients
Author Information
Author(s): Eija Kalso, Karen H Simpson, Robert Slappendel, Joachim Dejonckheere, Ute Richarz
Primary Institution: Helsinki University Central Hospital
Hypothesis
Can we predict which patients with low back pain will respond well to strong opioids?
Conclusion
A one-month trial period is generally sufficient to determine if patients will benefit from strong opioid treatment.
Supporting Evidence
- Over half the patients in both groups were treatment responders.
- The difference in response to treatment could be detected at 3 weeks.
- A lack of response after 1 month had a stronger negative predictive value than the presence of response.
Takeaway
Doctors want to know who will feel better with strong pain medicine, but it's hard to tell before they start. A month of trying the medicine usually shows if it helps.
Methodology
Secondary analysis of a 13-month randomized trial comparing transdermal fentanyl and sustained-release oral morphine.
Potential Biases
The study included only carefully selected patients with a long history of chronic low back pain.
Limitations
The study was not originally designed to test predictors, and many potentially important factors were not examined.
Participant Demographics
Median age 52 years, 61% women, median duration of back pain 87 months.
Statistical Information
P-Value
p = 0.0259
Confidence Interval
95% CI 1.77–5.68
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website